15-17 April, 2019

The Waldorf Hilton

London, UK

Pre-Conference Covance Workshop

Operational and Commercial Considerations for CDx – A Rapidly Evolving Landscape

Tuesday, 1st May, 2018

13.00 – 17.00

Join Covance and their panel of industry expert speakers before the start of Clinical Biomarkers & World CDx Europe in this workshop to take a deeper dive into the strategy behind the commercialisation of drug-CDx products. Benefit from multi-stakeholder perspectives, granular discussion and extended networking with the brightest biomarker, precision medicine and diagnostic minds in the field. This workshop will address the following topics:

Workshop Chair: Steve Anderson, Chief Scientific Officer, Covance

 

Topic One: Operational / Business Models

Tom Turi, Vice President, Companion Diagnostics, Covance

 

Topic Two: Regulatory Realities 

Seamus Kearney, CEO & Principal Consultant, ARC Regulatory

Jo Love, Associate Senior Clinical Consultant, ARC Regulatory

 

Topic Three: Commercial Strategy – Global Reach and Local Expertise

Pieter Van den Steen, Chief Commercial Officer, Unilabs Group

Jakob Gjørret, CEO/MD, Unilabs Denmark

 

Topic Four: Newly Established and Emerging Technologies

Tuc Ahmad, Scientific Director, Diagnostic Development, Covance

Chris van Haag, Senior Manager, Strategic Accounts, Biocartis

 

HOW TO APPLY

If you are interested in joining the pre-conference workshop hosted by Covance, please email ben.carrington@hansonwade.com. If accepted, the workshop will be free to attend as part of your conference registration. Confirmation of attendance will be given via email.